08/20/2025
3:12 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2025
3:13 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2025
3:11 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
7:23 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
7:24 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
7:25 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2025
3:31 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2025
3:29 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2025
3:16 PM | Stoke Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2025
6:00 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2025
11:14 AM | FMR LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for STOK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Stoke Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
07/15/2025
4:12 PM | BlackRock Portfolio Management LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
07/13/2025
11:15 PM | Stoke Therapeutics (Filer)
| Form EFFECT | |
07/10/2025
6:00 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
3:27 PM | Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:47 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
06/23/2025
3:16 PM | Hoitt Jason (Reporting)
Stoke Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2025
9:03 AM | FMR LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/04/2025
7:32 PM | Burstein Jennifer (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:33 PM | Harrison Seth Loring (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:34 PM | Krainer Adrian R. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:35 PM | Menzel Garry E (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:36 PM | LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:38 PM | Smith Julie (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:30 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:05 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
6:00 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
5:41 PM | BlackRock, Inc. (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/15/2025
4:04 PM | BlackRock Portfolio Management LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/20/2025
5:15 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:16 PM | LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:17 PM | Leggett Thomas (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:18 PM | Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:19 PM | SMITH IAN F (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:05 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:12 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:05 PM | Stoke Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2025
3:07 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:08 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad) Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary). |
02/18/2025
3:31 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:00 AM | RTW INVESTMENTS, LP (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
3:36 PM | MORGAN STANLEY (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/07/2025
6:06 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:14 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
4:23 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/27/2024
4:13 PM | Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
5:15 PM | Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
3:05 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
3:07 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
5:59 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4/A | |
12/10/2024
6:00 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
6:01 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
6:02 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
3:48 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
4:19 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:19 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:20 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:21 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:00 PM | Redmile Group, LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:24 PM | BAKER BROS. ADVISORS LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
8:00 AM | Lynx1 Capital Management LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
11/05/2024
3:15 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:05 PM | Stoke Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:56 PM | Stoke Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:50 PM | Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
3:16 PM | Stoke Therapeutics (Filer)
| Form S-3ASR | |
09/23/2024
3:22 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13D/A | |
09/23/2024
3:23 PM | Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
4:23 PM | Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:17 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:20 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access